Call for Abstract

7th International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics, will be organized around the theme “Comprehensive Overview of What Personalized Medicine Means Today”

Personalized Medicine 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Personalized Medicine 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

In medication, a biomarker and sub-atomic markers are the quantifiable pointer of the seriousness or vicinity of some infection state. All the more by and large a biomarker is anything that can be utilized as a marker of a specific ailment state or some other physiological condition of a living being Drug-Diagnostic Co-Development. In the present period of stratified solution and biomarker-driven treatments, the centre has moved from forecasts taking into account the conventional anatomic arranging frameworks to direct the decision of treatment for an individual patient to a coordinated methodology utilizing the hereditary cosmetics of the tumour and the genotype of the patient. Genomics and other innovations have to a great extent added to the recognizable proof and the improvement of biomarkers such as Stratification biomarkers in customized pharmaceutical. The late surge in high-throughput sequencing of growth genomes has upheld an extending atomic order of disease. These studies have recognized putative prescient biomarkers meaning unusual oncogene pathway initiation and might give a basis to coordinating patients with molecularly focused on treatments in clinical trials. Here, we examine a percentage of the difficulties of adjusting this information for uncommon growths or atomic subsets of specific tumours, which will require adjusting the accessibility of investigational operators, quick turnaround of clinical evaluation sequencing, sub-atomic qualification and re-examining Personalizing clinical trials with biomarkers outline and end focuses.

 

  • Track 1-1Emerging biomarkers
  • Track 1-2Drug diagnostic co-development
  • Track 1-3The Microbiome- A modifiable biomarker?
  • Track 1-4Biomarkers to clinical diagnostics
  • Track 1-5Biomarkers for autoimmune disease

Customized solution depends on interspecies contrasts. It is proverbial that little contrasts in hereditary make-up can bring about emotional contrasts because of medications or ailment and societal effect of customized pharmaceutical. To express this in more broad terms in any given complex framework, little changes in beginning conditions can bring about drastically diverse results. In spite of human variability and interspecies variety in different species, nonhuman species are still the essential model for finding out information for personalized solution wellbeing change in Human. We raise doubt about this practice and presume that human-based examination ought to be the essential means for acquiring information about human illnesses and reactions to medicates. Systems in the advancement and use of customized prescription were created for the exact results in personalized drug wellbeing change in Human and Animal Models.

  • Track 2-1Personalized medicine in pediatrics
  • Track 2-2 Clinical next generation sequencing testing
  • Track 2-3Personalized medicine in geriartrics
  • Track 2-4Personalized medicine adolcents
  • Track 2-5Personalized medicine pregnant women

Life Medicine (LM) is the utilization of way of life mediations in the treatment and administration of infection. LM is turning into the favoured methodology for the counteractive action as well as the treatment of most perpetual sicknesses, including Type-2 Diabetes, Coronary Heart Disease, Hypertension, Obesity, Insulin Resistance Syndrome, Osteoporosis, malignancy prevention. Likewise incorporate Aerobic and Resistance practices for patients with diabetes, Sleep and infection counteractive action, intrinsic inspiration and wellbeing conduct adherence.

  • Track 3-1Treatment option for chronic disease
  • Track 3-2 Physical activity & cardiovascular disorders: How much is enough?
  • Track 3-3Aerobic & resistance exercises for diabetic patients
  • Track 3-4Intrinsic motivation and health behaviour adherence
  • Track 3-5Psychological stress and disease
  • Track 3-6Cancer prevention and pain management
  • Track 3-7Practicing pathologists in personalized medicine

Preventive Medicine is honed by all doctors to keep their patients sound. It is additionally an exceptional medicinal claim to fame perceived by the American Board of Medical Specialties (ABMS). Preventive Medicine concentrates on the wellbeing of people, groups, and characterized populaces. It is likewise utilized for the treatment for stoutness, visual impairment. The Epidemiology Division applies research strategies to comprehend the examples and reasons for wellbeing and ailment in the populace and to make an interpretation of this learning into projects intended to avert malady. The division has a long history of inclusion in NIH-supported multi-site, longitudinal partner studies, and its personnel manage numerous specialist started, NIH-supported exploration ventures and trials. Open trust in antibodies is a key to the achievement of vaccination projects worldwide in the period of preventive prescription.

  • Track 4-1Predictive testing for diverse medical conditions
  • Track 4-2Treating ovarian cancer
  • Track 4-3Treatment of cardiovascular disease
  • Track 4-4Application in metabolic abnormalities
  • Track 4-5Neuropsychiatric conditions: Epilepsy

The era of personalized oncology medicine has the potential to fulfil the promise of delivering the right dose for the right indication to the right patient at the right time. Imagine your oncologist knowing before he makes a treatment decision how well your cancer may respond to a particular therapy. Tools that enable a more informed treatment decision do exist and may help individualize your cancer care. It is very important for oncologists to keep updated of the latest advancements in oncology as changes in management of cancer are quite common. All fit patients whose cancer progresses and no standard of care treatment options are available should be enrolled in a clinical trial. Personalized medicine is used to learn about a person’s genetic makeup and how their tumor grows. Using this data, doctors hope to find prevention, screening, and treatment strategies that may be more effective. They also want to find ones that cause fewer side effects than the standard treatments. By performing more genetic tests, doctors may customize treatment to each patient’s needs.

  • Track 5-1Diagnosis and staging of Personalized oncology
  • Track 5-2Risk factors
  • Track 5-3Screening of oncology

Clinical immunology is the study of diseases caused by disorders of the immune system. It also involves diseases of other systems, where immune reactions play a part in the pathology and clinical features. Many components of the immune system are actually cellular in nature and not associated with any specific organ but rather are embedded or circulating in various tissues located throughout the body. Immunotherapy is a new class of cancer treatment that works to harness the innate powers of the immune system to fight cancer. Because of the immune system's unique properties, these therapies may hold greater potential than current treatment approaches to fight cancer more powerfully, to offer longer-term protection against the disease, to come with fewer side effects, and to benefit more patients with more cancer types. Scientists believe that for most people, Alzheimer's disease results from a combination of genetic, lifestyle and environmental factors that affect the brain over time. In Parkinson’s disease, cells that produce dopamine start to die. Dopamine is a chemical that helps you move normally. There is no known direct cause of Parkinson’s. One theory is that it may be hereditary. Other theories say exposure to pesticides and living in rural communities may cause it.

  • Track 6-1Clinical immunology
  • Track 6-2Alzheimer’s disease
  • Track 6-3 Parkinson’s disease
  • Track 6-4Cancer immunology

The objective of the Cardiac Research is to quicken interpretation of promising new crucial examination revelations for the treatment of heart disappointment and arrhythmias through very much composed clinical trials that exhibit viability and security. Vascular Medicine envelops a wide range of different disease states. As the field of vascular Medicine develops, the extent of illnesses being dealt with changes. Cardiovascular renovating alludes to the adjustments in size, shape, structure and physiology of the heart after damage to the myocardium. The harm is normally because of intense myocardial dead tissue. To portray the expansion in lipoprotein interpretation by hypothyroidism, adipocytes were readied from control and hypothyroid rats. While LPL combination was higher in hypothyroid adipocytes, with no adjustment in mRNA levels, there was no expansion in hormone-touchy lipase (HSL) blend.

To figure out if an executing interpretation administrative component was available, a cytoplasmic portion was readied from control and hypothyroid adipocytes, and added to an in vitro interpretation framework containing the hLPL mRNA. Clinical results with non-biologic treatment, given ahead of schedule over the span of the ailment, are in the same class as with biologic treatments. Mixes of medicines are normally required to accomplish quick and supported reduction.

  • Track 7-1Stem cells in cardiac and vascular regeneration
  • Track 7-2Metabolic and lipoprotein translation
  • Track 7-3 Angiology

Personalized Medicine is a developing routine of medication that uses an individual's hereditary profile to guide choices made with respect to the counteractive action, determination, and treatment of ailment. Information of a patient's hereditary profile can offer specialists some assistance with selecting the best possible prescription or treatment and manage it utilizing the correct measurement or regimen. Utilized for the treatment as Personalized growth solution, Diabetes-related sickness: hazard appraisal and administration, Personalized pharmaceutical: New procedures and monetary ramifications, Implications of customized prescription in treatment of HIV, Applications of customized drug in uncommon illnesses, Translational Medicine.

  • Track 8-1Personalised medicine in healthcare
  • Track 8-2Horizons of personalized medicine
  • Track 8-3Realizing the value of personalized medicine
  • Track 8-4Biobanking: Transforming healthcare
  • Track 8-5Drug designing in personalized medicine
  • Track 8-6Future of personalized medicine

Personalized Medicine is a developing routine of medication that uses an individual's hereditary profile to guide choices made with respect to the counteractive action, determination, and treatment of ailment. Information of a patient's hereditary profile can offer specialists some assistance with selecting the best possible prescription or treatment and manage it utilizing the correct measurement or regimen. Utilized for the treatment as Personalized growth solution, Diabetes-related sickness: hazard appraisal and administration, Personalized pharmaceutical: New procedures and monetary ramifications, Implications of customized prescription in treatment of HIV, Applications of customized drug in uncommon illnesses, Translational Medicine.

  • Track 9-1Therapeutics and diagnostics
  • Track 9-2Preclinical and clinical diagnostics
  • Track 9-3Translational research
  • Track 9-4Liquid biopsy
  • Track 9-5Personalized imaging
  • Track 9-6Diagnostic assays

P4 Medicine is an arrangement to profoundly enhance the nature of human life by means of biotechnology. P4 Medicine is a term authored by scholar Leroy Hood, and is another way to say "Predictive, Preventive, Personalized Medicine, and Molecular Medicine." The reason of P4 Medicine is that, throughout the following 20 years, restorative practice will be altered by biotechnology, to deal with a man's wellbeing, rather than deal with a patient's infection. Inner solution or general medication (in Commonwealth countries) is the medicinal claim to fame managing the avoidance, determination, and treatment of grown-up maladies. Crisis solution is a medicinal claim to fame including watch over grown-up and paediatric patients with intense sicknesses or wounds that require quick therapeutic consideration.

  • Track 10-1Strategic analysis of industry trends
  • Track 10-2Companion diagnostic market
  • Track 10-3Personalized medicine & targeted therapeutics
  • Track 10-4New strategies & economic implications
Personalized  drug is a field of medication that involves foreseeing the likelihood of malady and establishing preventive measures keeping in mind the end goal to either keep the ailment by and large or altogether abatement its effect upon the patient, (for example, by avoiding mortality or constraining dreariness). Methods and measures incorporate New-born screening, Diagnostic testing, Medical bioinformatics, Prenatal testing, Carrier testing, Preconception testing. Infant screening is a general wellbeing program intended to screen babies not long after conception for a rundown of conditions that are treatable, however not clinically clear in the infant period. Pre-birth testing: Prenatal testing is utilized to search for sicknesses and conditions in a hatchling or developing life before it is conceived. This kind of testing is offered for couples who have an expanded danger of having a child with a hereditary or chromosomal issue. Screening can decide the sex of the embryo. Pre-birth testing can offer a couple some assistance with deciding whether to prematurely end the pregnancy. Like symptomatic testing, pre-birth testing can be non-invasive or intrusive. Non-obtrusive procedures incorporate examinations of the lady's womb through ultrasonography or maternal serum screens. These non-intrusive procedures can assess danger of a condition, however can't decide with conviction if the embryo has a condition.
  • Track 11-1Healthcare using pharmacogenomics
  • Track 11-2Personalised medicine for cancer
  • Track 11-3Personalised medicine for cardiovascular diseases
  • Track 11-4Personalised medicine for diabetes
  • Track 11-5Personalised medicine for obesity
  • Track 11-6Personalised approach in psychological disorders
  • Track 11-7Target based personalized therapy
Personalized Medicine is a developing routine of prescription that uses an individual's hereditary profile to guide choices made with respect to the counteractive action, analysis, and treatment of malady. Learning of a patient's hereditary profile can offer specialists some assistance with selecting the correct prescription or treatment and control it utilizing the best possible measurements or regimen. Utilized for the treatment as Personalized malignancy pharmaceutical, Diabetes-related sickness: hazard evaluation and administration, Personalized drug: New procedures and monetary ramifications, Implications of customized medication in treatment of HIV, Applications of customized prescription in uncommon infections, Translational Medicine.
  • Track 12-1Implications of personalized medicine in treatment of HIV
  • Track 12-2Treatment of neuropsychiatric disorders
  • Track 12-3New born screening & prenatal testing
  • Track 12-4Applications in treating rare diseases
  • Track 12-5Development of personalized genetic medicine

Genetic disorders may or may not be heritable from the parents genes. In non-heritable genetic disorders, defects may be caused by new mutations  and changes to the DNA. In such cases, the defect will only be heritable if it occurs in the germ line .Such as some forms of cancer, may be caused by an inherited genetic condition in some people by new mutations in other people, and mainly by environmental causes in other people. Whether, when and to what extent a person with the genetic defect abnormality will actually suffer from the disease is almost always affected by the environmental factors and events in the persons development.

  • Track 13-1Molecular diagnostics in genetic disorders
  • Track 13-2Biomarkers in genetic disorders
  • Track 13-3Personalized treatment of cystic fibrosis
  • Track 13-4New era of Proteomics
  • Track 13-5Protein microarrays for personalized medicine
Genomics is a control in hereditary qualities that applies Recombinant DNA, DNA sequencing techniques, and bioinformatics to grouping, amass, and break down the capacity and structure of genomes. Propels in genomics have set off an insurgency in disclosure based examination to see even the most complex organic frameworks, for example, the mind. The field incorporates endeavours to decide the whole DNA grouping and human genome variation of life forms and fine-scale hereditary mapping. The field additionally incorporates investigations of intragenomic marvels, for example, heterosis, epistasis, pleiotropy and different associations in the middle of loci and all within the genome and met genomics. Near genomics is an energizing new field of natural exploration in which the genome groupings of various species human, mouse and a wide assortment of different life forms from yeast to chimpanzees are thought about.
  • Track 14-1Genomic evaluation by personalized studies
  • Track 14-2 Human genome variation
  • Track 14-3Biomedical informatics
  • Track 14-4Metagenomics & comparative genomics
  • Track 14-5Genetics informed personalized immunotherapy
  • Track 14-6Data solutions in clinical genomics
  • Track 14-7Controlling outburst of mutations

Arrangement investigation of Ebola infection Genome is the second through the 6th qualities of the Ebola infection (EBO) genome demonstrates that it is sorted out also to rhabdoviruses and paramyxoviruses and is for all intents and purposes the same as Marburg infection (MBG). Researchers utilized genomic sequencing advancements to recognize the starting point and track transmission of the Ebola infection in the ebb and flow flare-up in Africa.

  • Track 15-1Ebola virus genome
  • Track 15-2Genomic sequencing technologies: Identify Ebola virus
Personalized Medicine can be utilized to find out around a man's hereditary cosmetics and to disentangle the science of their tumour. Utilizing this data, specialists want to recognize anticipation, screening, and treatment techniques that might be more successful and cause less symptoms than would be normal with standard medicines. By performing more hereditary tests and examination, specialists might alter treatment to every patient's needs. Making a customized malignancy screening and treatment arrangement incorporates: Determining the odds that a man will create growth and selecting screening techniques to bring down the danger, Matching patients with medications that will probably be compelling and cause less reactions, Predicting the danger of repeat (return of Cancer)
  • Track 16-1Cell based therapy
  • Track 16-2Molecular mechanisms
  • Track 16-3Personalized medicine in organ transplantation
  • Track 16-4Controlling proliferation
Nanotechnology ("nanotech") is the control of matter on a nuclear, atomic, and supramolecular scale. The soonest, across the board portrayal of nanotechnology alluded to the specific mechanical objective of accurately controlling particles and atoms for creation of macro scale items, likewise now alluded to as sub-atomic nanotechnology. Uses of pharmaceutical Nano tools, Cell based treatment Molecular systems are the strategies and instrument in Nano innovation and biotechnology.
  • Track 17-1Contribution towards personalized medicine.
  • Track 17-2Significance of pharmaceutical Nano tools
  • Track 17-3Nanobioscience: Advance therapy
  • Track 17-4Role of metabolomics
  • Track 17-5Bioinformatics in personalized medicine
  • Track 17-6Biosensors in personalized medicine